Mrs. RIZWANA

Booked For Processed By
Dr Anupam Garg Modinagar New, GT Road, Jeevan Hospital Meerut, 8,9‐ Begum Bridge Road, Opposite City Center,Bacha
Bank Colony Modinagar UP‐ 201204, ‐ 201204 Park, ‐ 250002
Contact No. ‐9917474173 Contact No. ‐7827949754
Name : Mrs. RIZWANA Billing Date : 02/05/2024 10:35:36 AM

Age/Gender : 25 Yrs/Female Sample Collected on : 02/05/2024 10:35:39 AM
P. ID No. : 1100D19820245023 Sample Received on : 02/05/2024 12:48:06 PM
Accession No : 1100D19820245020001 Report Released on : 02/05/2024 02:58:00 PM
Referring Doctor :
Referred By : Self
Report Status -Preliminary

Test Name Result Biological Ref. Interval Unit
HEALTHKIND COMPLETE
Vitamin Profile
BIOCHEMISTRY
Vitamin D 25 - Hydroxy 3.06 L Deficiency : < 20 ng/mL

Sample : Serum Insufficiency : 20 - 30
Method : ECLIA Sufficiency : 30 - 100
Toxicity > 100
Vitamin B12 / Cobalamin

Sample : Serum
Method : ECLIA
Vitamin B12 476.70 197.00 - 771.00 pg/mL
BIOCHEMISTRY
Fasting Plasma Glucose

Sample : Plasma Fluoride - Fasting
Method : Hexokinase
Plasma Glucose, Fasting 77.70 Normal : 74 - 99 mg/dL

Impaired Fasting
Glucose : 100 -
125
Diabetes : > 126
Lipid Profile
Sample : Serum
Total Cholesterol 111.18 No Risk : < 200 mg/dL
Page No: 1 of 13

Referring Doctor :
Referred By : Self

Method : CHOD/PAP Moderate Risk :

200 - 239
High Risk : > 240
Triglycerides 69.50 Desirable : < 150 mg/dL
Method : Enzymatic ,end point (GPO- PAP) Boderline High :
150 - 199
High : 200 - 499
Very High :
>=500
LDL Cholesterol (Calculated) 61.22 0.00 - 100.00 mg/dL
Method : Calculated
HDL Cholesterol 36.06 L Low : < 40 mg/dL
Method : Direct Measure-PEG Optimal : 40 - 60
High : > 60
VLDL Cholesterol 13.90 Desirable : 10 - mg/dL
Method : Calculated 35
Total Cholesterol / HDL Ratio 3.08 L Low Risk : 3.3 - Ratio
Method : Calculated 4.4
Average Risk : 4.5
- 7.0
Moderate Risk :
7.1 - 11.0
High Risk : > 11.0
LDL / HDL Ratio 1.70 Low Risk : 0.5 - Ratio
Moderate Risk :
3.1 - 6.0
High Risk : > 6.0
Non HDL Cholesterol 75.12 0.00 - 130.00 mg/dL
Method : Calculated
Liver Function Test (LFT)
Page No: 2 of 13

Referring Doctor :
Referred By : Self

Sample : Serum
Bilirubin Total 0.33 0.00 - 1.20 mg/dL

Method : DIAZO
Bilirubin Direct 0.15 0.00 - 0.20 mg/dL
Method : DIAZO
Serum Bilirubin (Indirect) 0.18 0.00 - 0.90 mg/dL
Method : Calculated
SGOT / AST 17.52 0.00 - 32.00 U/L
Method : UV Without P5P (Pyridoxal 5
Phosphatse)
SGPT / ALT 13.22 0.00 - 33.00 U/L
Method : UV With P5P (Pyridoxal 5 Phosphatse)
AST / ALT Ratio 1.33 - Ratio
Method : Calculated
Alkaline Phosphatase 168.24 H 35.00 - 104.00 U/L
Method : PNPP, AMP Buffer
Total Protein 6.78 6.40 - 8.30 gm/dL
Method : BIURET
Albumin 4.43 3.97 - 4.94 gm/dL
Method : Bromo Cresol Green(BCG)
Globulin 2.35 1.90 - 3.70 gm/dL
Method : Calculated
Albumin Globulin A/G Ratio 1.89 1.00 - 2.10 Ratio
Method : Calculated
Gamma-Glutamyl Transferase ( GGT )

Sample : Serum
Method : G- Glutamyl-Carboxy- Nitroanilide
Page No: 3 of 13

Referring Doctor :
Referred By : Self

Gamma-Glutamyl Transferase (GGT) 6.89 6.00 - 42.00 U/L
Kidney Function Test

Sample : Serum
Blood Urea Nitrogen 6.95 L 7.00 - 18.69 mg/dL

Method : Calculated
Blood Urea 14.88 L 15.00 - 40.00 mg/dL
Method : Urease UV
Creatinine 0.34 L 0.50 - 1.10 mg/dL
Method : Jaffe Kinetic IDMS
BUN Creatinine Ratio 20.45 H 10.00 - 20.00 Ratio
Method : Calculated
Calcium 8.18 L 8.60 - 10.00 mg/dL
Method : NM-BAPTA Complex
Uric Acid 2.59 2.40 - 5.70 mg/dL
Method : Uricase
Sodium 134.00 L 136.00 - 145.00 mmol/L
Method : ISE-Indirect
Potassium 3.50 3.50 - 5.10 mmol/L
Chloride 108.00 H 97.00 - 107.00 mmol/L
Total Protein 6.78 6.40 - 8.30 gm/dL
Method : BIURET
Albumin 4.43 3.97 - 4.94 gm/dL
Method : Bromo Cresol Green(BCG)
Globulin 2.35 1.90 - 3.70 gm/dL
Method : Calculated
Albumin Globulin A/G Ratio 1.89 1.00 - 2.10 Ratio
Page No: 4 of 13

Referring Doctor :
Referred By : Self

Method : Calculated
Iron Studies (Iron, TIBC, UIBC, % Saturation)

Sample : Serum
Iron 65.96 37.00 - 145.00 µg/dL

Method : Ferrozine
UIBC 264.07 110.00 - 370.00 µg/dL
Method : Ferrozine
Total Iron Binding Capacity (TIBC) 330.03 228.00 - 428.00 µg/dL
Method : Calculated
% Saturation 19.99 L 20.00 - 50.00 %
Method : Calculated
CLINICAL PATHOLOGY
Urine Routine & Microscopic Examination

Sample : Urine, Random
Colour, Urine Pale Yellow Pale Yellow ---

Method : VisualExamination
Appearance Slightly Hazy Clear ---
Method : VisualExamination
Specific Gravity 1.010 1.00 - 1.04 ---
Method : Ionic concentration method
pH 7.00 4.70 - 7.50 ---
Method : Double indicator principle
Glucose Not Detected Not Detected ---
Method : Bendict's Method
Protein Not Detected Not Detected ---
Page No: 5 of 13

Referring Doctor :
Referred By : Self

Method : Protein-Error ofindicator Principal

Ketones Not Detected Not Detected ---
Method : Rothera's Method
Blood Not Detected Not Detected ---
Method : Peroxidase
Bilirubin Not Detected Not Detected ---
Method : Diazo-Reaction / Fouchets Test
Urobilinogen Normal Normal ---
Method : Ehrlich's Reaction
Nitrite Not Detected Not Detected ---
Method : Nitrite Test
Pus Cells 3-5 0-5 /hpf
Method : Microscopy
RBC Not Detected Not Detected /hpf
Method : Microscopy
Epithelial Cells 2-3 0-5 /hpf
Method : Microscopy
Casts Not Detected Not Detected ---
Method : Microscopy
Crystals Not Detected Not Detected ---
Method : Microscopy
Bacteria Not Detected Not Detected ---
Method : Microscopy
Remarks Microscopic examination has been performed on urine
Method : Manual sediment.
HAEMATOLOGY
Page No: 6 of 13

Referring Doctor :
Referred By : Self

Complete Blood Count (CBC)

Sample : Whole Blood, EDTA
Haemoglobin (Hb) 12.10 12.00 - 15.00 gm/dL

Method : Spectophotometry method by cyanide
free
Total WBC Count / TLC 4.76 4.00 - 10.00 thou/µL
Method : Impedance
RBC Count 3.79 L 3.80 - 4.80 million/µL
Method : Impedance
PCV / Hematocrit 34.80 L 36.00 - 46.00 %
Method : Impedance
MCV 91.80 83.00 - 101.00 fL
Method : Calculated
MCH 31.90 27.00 - 32.00 pg
Method : Calculated
MCHC 34.70 H 31.50 - 34.50 gm/dL
Method : Calculated
RDW (Red Cell Distribution Width) 15.30 11.90 - 15.50 %
Method : Calculated
Neutrophils 54.00 40.00 - 80.00 %
Method : Microscopy/Flow cytometry
Lymphocytes 34.00 20.00 - 40.00 %
Method : "Microscopy/Flow cytometry (Leishman
Stain)"
Eosinophils 3.00 1.00 - 6.00 %
Monocytes 9.00 2.00 - 10.00 %
Basophils 0.00 0.00 - 2.00 %
Page No: 7 of 13

Referring Doctor :
Referred By : Self


Absolute Neutrophil Count (ANC) 2570.40 2000.00 - /µL
Absolute Lymphocyte Count 1618.40 1000.00 - /µL
Absolute Eosinophil Count (AEC) 142.80 20.00 - 500.00 /µL
Method : Calculated
Absolute Monocyte Count 428.40 200.00 - 1000.00 /µL
Method : Calculated
Absolute Basophil Count 0.00 L 20.00 - 100.00 /µL
Method : Calculated
Platelet Count 289.00 150.00 - 410.00 thou/µL
Method : Impedance
MPV (Mean Platelet Volume) 10.00 6.80 - 10.90 fL
Method : Calculated
Erythrocyte Sedimentation Rate (ESR) 5.00 0.00 - 12.00 mm Ist

Sample : Whole Blood, EDTA Hour
Method : Capillary Photometry
SEROLOGY
Hepatitis B Surface Antigen (HBsAg), Non Reactive Non Reactive ---

Rapid Card
Sample : Serum
Method : Immunochromatography
Remarks
Please note that rapid test is a sensitive and reliable screening test, it should not be used as a solo criterion for
diagnosis. It is recommended to use molecular testing (PCR) for confirmation.
Page No: 8 of 13

Referring Doctor :
Referred By : Self

HEALTHKIND COMPLETE
BIOCHEMISTRY
Phosphorus
Sample : Serum
Method : Phospho Molybdate
Phosphorus Serum 3.32 2.50 - 4.50 mg/dL
Thyroid Profile Total

Sample : Serum
Method : ECLIA
Total T3 (Triiodothyronine) 1.32 0.80 - 2.00 ng/mL

Total T4 (Thyroxine) 6.74 5.10 - 14.10 µg/dL
TSH 3rd Generation 8.840 H 0.27 - 4.20 µIU/mL
HAEMATOLOGY
HbA1C (Glycosylated Hemoglobin)

Sample : Whole Blood, EDTA
HbA1c 5.00 0.00 - 5.60 %

Method : Immunoassay & Reflectometry
Mean Plasma Glucose 96.80 0.00 - 116.00 mg/dL
Method : Calculated
Interpretation
Vitamin B12 / Cobalamin
Vitamin B12 is necessary for hematopoiesis and normal neuronal function. It requires intrinsic factor (IF) for absorption. Vitamin B12 deficiency may be due
Page No: 9 of 13

Referring Doctor :
Referred By : Self

to lack of IF secretion by gastric mucosa (eg, gastrectomy, gastric atrophy) or intestinal malabsorption (eg, ileal resection, small intestinal diseases). Vitamin
B12 deficiency results in macrocytic anemia, glossitis, peripheral neuropathy, weakness, hyperreflexia, ataxia, loss of proprioception, poor coordination, and
affective behavioral changes.
Vitamin D 25 - Hydroxy
The 25-hydroxy vitamin D test is used to detect bone weakness or other bone malfunctions or disorders that occur as a result of a vitamin D deficiency.Those
who are at high risk of having low levels of vitamin D include people who don’t get much exposure to the sun, older adult, people with obesity, babies who
are breastfed only, post gastric bypass surgery, Crohn’s disease and other intestinal malabsorption conditions. Hypervitaminosis D usually occurs due to over
intake of Vitamin D supplementation.
Phosphorus
Phosphorus deficiencies (hypophosphatemia) may be seen with malnutrition, malabsorption, acid-base imbalances, increased blood calcium, and disorders that
affect kidney function. And phosphorus excesses (hyperphosphatemia) may be seen with increased intake of the mineral, low blood calcium, and kidney
dysfunction.
Thyroid Profile Total

Patient preparation is particularly important for hormone studies, results of which may be markedly affected by many factors such as stress, position,
fasting state, time of the day, preceding diet & drug therapy.
T3 is one of the thyroid hormones derived due to peripheral conversion of T4. The levels of T3 helps in the diagnosis of T3 Thyrotoxicosis and
monitoring the course of hypothyroidism. However, T3 is not recommended for diagnosis of hyperthyroidism as decreased values have minimal clinical
significance. Values below the lower limits can be caused by a number of conditions including non-thyroidal illness, acute and chronic stress and
hypothyroidism.
Elevated level of T4 is seen in hyperthyroidism, pregnancy, euthyroid patients with increased serum TBG. Decreased levels are noted in hypothyroidism,
hypoproteinemia, euthyroid sick syndrome, decrease in TBG.
TSH controls biosynthesis and release of thyroid hormones T3 & T4. TSH levels are increased in primary hypothyroidism, insufficient thyroid hormone
replacement therapy, Hashimotos thyroiditis, use of amphetamines, dopamine antagonists, iodine containing agents, lithium, and iodide induced or
deficiency goiter.
Kidney Function Test

Kidney function tests (KFT) are usually ordered when a patient has risk factors for kidney dysfunction such as high blood pressure (hypertension), diabetes,
cardiovascular disease, obesity, elevated cholesterol or a family history of kidney disease. It may also be ordered when someone has signs and symptoms of
kidney disease, though in early stage often no noticeable symptoms are observed. Kidney panel is useful for general health screening; screening patients at risk
of developing kidney disease; management of patients with known kidney disease.
Page No: 10 of 13

Referring Doctor :
Referred By : Self

Iron Studies (Iron, TIBC, UIBC, % Saturation)

IRON:
Serum Iron is normal or low in iron deficient anaemia, pregnancy, patients taking oral contraceptive medications,in chronic inflammatory and malignancies.
Serum Iron is high in hereditary hemochromatosis and in iron overload states.
Total Iron Binding Capacity (TIBC):

Transferrin is the primary plasma iron transport protein but accounts for 25% to 30% saturation with iron. The additional amount of iron that can be bound is
the unsaturated iron-binding capacity (UIBC). The total iron-binding capacity (TIBC) can be indirectly determined using the sum of the serum iron and UIBC.
TIBC levels are usually low when serum Iron levels are high and vice versa.
UIBC:
UIBC measurements can be used in conjunction with serum iron concentration to obtain the total-iron binding capacity (TIBC) i.e. the maximum
concentration of iron that serum proteins, principally transferrin, can bind. TIBC is decreased in chronic infections, malignancy, in iron poisoning, renal
disease, nephrosis, kwashiorkor and
thalassemia. Common causes for an increase in TIBC
% Saturation:
Levels of Transferring Saturation are useful to indicate inadequate iron supply ( <16 %) and to detect hemochromatosis (>55 % for males / >50 % for
females).
Liver Function Test (LFT)

Indications for liver function assessment includes:
Screen for liver infections, such as hepatitis

Monitor the progression of a disease, such as viral or alcoholic hepatitis, and determine how well a treatment is working
Measure the severity of a disease, particularly scarring of the liver (cirrhosis)
Monitor possible side effects of medications
Lipid Profile
COMMENTS / INTERPRETATION :
Lipid Profile consist of Triglycerides, Cholesterol and other lipoprotein fractions in serum. The levels reflect the status of Lipid metabolism in the body, collectively they aid in the
diagnosis of various abnormal hyper lipidaemias. Analysis of Lipids has assumed greater importance due to increasing prevalence rates of Ischaemic Heart Diseases (IHD).
NCEP (ATP III) Guidelines.
Page No: 11 of 13

Referring Doctor :
Referred By : Self

Urine Routine & Microscopic Examination

Urine routine examination and microscopy comprises of a set of screening tests that can detect some common diseases like urinary tract infections, kidney disorders, liver problems,
diabetes or other metabolic conditions. Physical characteristics (colour and appearance), chemical composition(glucose, protein, ketone, blood, bilirubin and urobilinogen) and
microscopic content ( pus cells, epithelial cells, RBCs, casts and crystals) are analyzed and reported.
Erythrocyte Sedimentation Rate (ESR)

The erythrocyte sedimentation rate (ESR) is a simple but non‑specific test that helps to detect inflammation associated with conditions such as infections,
cancers, and autoimmune diseases.
HbA1C (Glycosylated Hemoglobin)

Hemoglobin A1c (HbA1c) level reflects the mean glucose concentration over the previous period (approximately 8-12 weeks) and provides a much better indication of long-term
glycemic control than blood and urinary glucose determinations. American Diabetes Association (ADA) include the use of HbA1c to diagnose diabetes, using a cutpoint of 6.5%. The
ADA recommends measurement of HbA1c 3-4 times per year for type 1 and poorly controlled type 2 diabetic patients, and 2 times per year for well-controlled type 2 diabetic
patients) to assess whether a patient's metabolic control has remained continuously within the target range. Falsely low HbA1c results may be seen in conditions that shorten
erythrocyte life span. and may not reflect glycemic control in these cases accurately.
Complete Blood Count (CBC)

CBC comprises of estimation of the cellular componenets of blood including RBCs, WBCs and Platelets. Mean corpuscular volume (MCV) is a measure of the size of the average RBC,
MCH is a measure of the hemoglobin cointent of the average RBC and MCHC is the hemoglobin concentration per RBC. The red cell distribution width (RDW) is a measure of the
degree of variation in RBC size (anisocytosis) and is helpful in distinguishing between some anemias. CBC examination is used as a screening tool to confirm a hematologic disorder,
to establish or rule out a diagnosis, to detect an unsuspected hematologic disorder, or to monitor effects of radiation or chemotherapy. Abnormal results may be due to a primary
disorder of the cell-producing organs or an underlying disease. Results should be interpreted in conjunction with the patient's clinical picture and appropriate additional testing
performed.
Hepatitis B Surface Antigen (HBsAg), Rapid Card

Hepatitis B surface antigen (HBsAg) is the first serologic marker appearing in the serum at 6 to 16 weeks following exposure to HBV. In acute infection,
HBsAg usually disappears in 1 to 2 months after the onset of symptoms. Persistence of HBsAg for more than 6 months in duration indicates development of
either a chronic carrier state or chronic HBV infection.
In case of negative results:
Please note that while rapid test is a sensitive and reliable screening test, it should not be used as a sole criterion for diagnosis. It is recommended to use
Page No: 12 of 13

Referring Doctor :
Referred By : Self

molecular testing (PCR) for confirmation.
In case of positive results:
The test has been performed on two different rapid technologies. Please note that while rapid test is a sensitive and reliable screening test, it should not be
used as a sole criterion for diagnosis. It is recommended to use molecular testing (PCR) for confirmation.
** End of Report **
Authenticated By
Dr. Akash Jain

MBBS MD (Pathology)
Lab Head
Page No: 13 of 13

Mrs. RIZWANA

Uploaded by

Copyright:

Available Formats

You might also like

Mrs. RIZWANA

Uploaded by

Document Information

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Mrs. RIZWANA

Uploaded by

Copyright:

Available Formats

Booked For Processed By

Name : Mrs. RIZWANA Billing Date : 02/05/2024 10:35:36 AM

Report Status -Preliminary

Vitamin D 25 - Hydroxy 3.06 L Deficiency : < 20 ng/mL

Vitamin B12 / Cobalamin

Vitamin B12 476.70 197.00 - 771.00 pg/mL

Fasting Plasma Glucose

Plasma Glucose, Fasting 77.70 Normal : 74 - 99 mg/dL

Total Cholesterol 111.18 No Risk : < 200 mg/dL

Name : Mrs. RIZWANA Billing Date : 02/05/2024 10:35:36 AM

Report Status -Preliminary

Method : CHOD/PAP Moderate Risk :

Liver Function Test (LFT)

Name : Mrs. RIZWANA Billing Date : 02/05/2024 10:35:36 AM

Report Status -Preliminary

Bilirubin Total 0.33 0.00 - 1.20 mg/dL

Gamma-Glutamyl Transferase ( GGT )

Name : Mrs. RIZWANA Billing Date : 02/05/2024 10:35:36 AM

Report Status -Preliminary

Gamma-Glutamyl Transferase (GGT) 6.89 6.00 - 42.00 U/L

Kidney Function Test

Blood Urea Nitrogen 6.95 L 7.00 - 18.69 mg/dL

Name : Mrs. RIZWANA Billing Date : 02/05/2024 10:35:36 AM

Report Status -Preliminary

Iron Studies (Iron, TIBC, UIBC, % Saturation)

Iron 65.96 37.00 - 145.00 µg/dL

Urine Routine & Microscopic Examination

Colour, Urine Pale Yellow Pale Yellow ---

Name : Mrs. RIZWANA Billing Date : 02/05/2024 10:35:36 AM

Report Status -Preliminary

Method : Protein-Error ofindicator Principal

Name : Mrs. RIZWANA Billing Date : 02/05/2024 10:35:36 AM

Report Status -Preliminary

Complete Blood Count (CBC)

Haemoglobin (Hb) 12.10 12.00 - 15.00 gm/dL

Name : Mrs. RIZWANA Billing Date : 02/05/2024 10:35:36 AM

Report Status -Preliminary

Method : Microscopy/Flow cytometry

Erythrocyte Sedimentation Rate (ESR) 5.00 0.00 - 12.00 mm Ist

Hepatitis B Surface Antigen (HBsAg), Non Reactive Non Reactive ---

Name : Mrs. RIZWANA Billing Date : 02/05/2024 10:35:36 AM

Report Status -Preliminary

Phosphorus Serum 3.32 2.50 - 4.50 mg/dL

Thyroid Profile Total

Total T3 (Triiodothyronine) 1.32 0.80 - 2.00 ng/mL

HbA1C (Glycosylated Hemoglobin)

HbA1c 5.00 0.00 - 5.60 %

Name : Mrs. RIZWANA Billing Date : 02/05/2024 10:35:36 AM

Report Status -Preliminary

Thyroid Profile Total

Kidney Function Test

Name : Mrs. RIZWANA Billing Date : 02/05/2024 10:35:36 AM

Report Status -Preliminary

Iron Studies (Iron, TIBC, UIBC, % Saturation)

Total Iron Binding Capacity (TIBC):

Liver Function Test (LFT)

Screen for liver infections, such as hepatitis

NCEP (ATP III) Guidelines.

Name : Mrs. RIZWANA Billing Date : 02/05/2024 10:35:36 AM